Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
46M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
14.6M
-
Shares change
-
+165K
-
Total reported value, excl. options
-
$18M
-
Value change
-
+$198K
-
Put/Call ratio
-
1.67
-
Number of buys
-
11
-
Number of sells
-
-10
-
Price
-
$1.24
Significant Holders of Theratechnologies Inc. - Common Shares (THTX) as of Q3 2024
40 filings reported holding THTX - Theratechnologies Inc. - Common Shares as of Q3 2024.
Theratechnologies Inc. - Common Shares (THTX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.6M shares
of 46M outstanding shares and own 31.67% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (4.8M shares), AIGH Capital Management LLC (3.73M shares), Nantahala Capital Management, LLC (2.68M shares), MORGAN STANLEY (2.25M shares), NATIONAL BANK OF CANADA /FI/ (187K shares), OSAIC HOLDINGS, INC. (145K shares), Cyndeo Wealth Partners, LLC (131K shares), Federation des caisses Desjardins du Quebec (85.5K shares), STIFEL FINANCIAL CORP (80.8K shares), and HARBOUR INVESTMENTS, INC. (73.1K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.